Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-002908
Filing Date
2019-04-10
Accepted
2019-04-10 09:12:34
Documents
104
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20181231x10k.htm 10-K 3513656
2 EX-23.1 jagx-20181231ex231af4bb9.htm EX-23.1 3031
3 EX-31.1 jagx-20181231ex311e006c6.htm EX-31.1 12122
4 EX-31.2 jagx-20181231ex3128ec37d.htm EX-31.2 12107
5 EX-32.1 jagx-20181231ex321f11b3c.htm EX-32.1 6538
6 EX-32.2 jagx-20181231ex3222609ee.htm EX-32.2 6520
7 GRAPHIC jagx20181231x10k001.jpg GRAPHIC 23407
  Complete submission text file 0001558370-19-002908.txt   13672325

Data Files

Seq Description Document Type Size
8 EX-101.INS jagx-20181231.xml EX-101.INS 2569511
9 EX-101.SCH jagx-20181231.xsd EX-101.SCH 114400
10 EX-101.CAL jagx-20181231_cal.xml EX-101.CAL 102954
11 EX-101.DEF jagx-20181231_def.xml EX-101.DEF 581068
12 EX-101.LAB jagx-20181231_lab.xml EX-101.LAB 905966
13 EX-101.PRE jagx-20181231_pre.xml EX-101.PRE 824483
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 19740675
SIC: 2834 Pharmaceutical Preparations